You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ETRA Conversion Disclosure
Orbimed Advisors Llc · SEC Form 4 · Filed Sep 23, 2026
Conversion
Calculated transaction value
$0
Orbimed Advisors Llc Director / Ten Percent Owner
ETRA
Transaction date
Sep 21, 2026
Public filing date
Sep 23, 2026
Filing lag
Filed 2 days later
ETRA daily price context
No linked price history
This asset is not matched to a market-data symbol.
Source details
- Reported owner
- Not disclosed
- Source asset code
- Derivative
- Security
- Series B Convertible Preferred Stock on Common Stock
- Quantity / price
- 1,087,934 shares @ $0
- SEC ownership
- Indirect
- Transaction code
- C
- Form
- 4
- Filing identifier
- 0000947871-26-000880
Filing cohort
Transactions in this filing
Showing 10 of 10
Trades
10
Issuers
1
Estimated value
$20M
Buys / sales
2 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Electra Therapeutics, Inc. ETRA | Buy | Sep 21, 2026 | $5M |
| Electra Therapeutics, Inc. ETRA | Conversion | Sep 21, 2026 | Not reported |
| Electra Therapeutics, Inc. ETRA | Buy | Sep 21, 2026 | $15M |
| Electra Therapeutics, Inc. ETRA | Conversion | Sep 21, 2026 | $0 |
| Electra Therapeutics, Inc. ETRA | Conversion | Sep 21, 2026 | $0 |
| Electra Therapeutics, Inc. ETRA | Conversion | Sep 21, 2026 | $0 |
| Electra Therapeutics, Inc. ETRA | Conversion | Sep 21, 2026 | Not reported |
| Electra Therapeutics, Inc. ETRA | Conversion | Sep 21, 2026 | Not reported |
| Electra Therapeutics, Inc. ETRA | Conversion | Sep 21, 2026 | Not reported |
| Electra Therapeutics, Inc. ETRA Current | Conversion | Sep 21, 2026 | $0 |